Morgan Stanley Maintains Underweight on CSX, Raises Price Target to $32

Benzinga Newsdesk www.benzinga.com Positive 77.3%

Neg 0% Neu 0% Pos 77.3%

Morgan Stanley analyst Ravi Shanker maintains CSX (NASDAQ:CSX) with a Underweight and raises the price target from $30 to $32.